These outcomes, along with a previous report exhibiting that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 support the strategy of concentrating on ACKR3 as a unique way to modulate the opioid technique, which could open up new therapeutic avenues for opioid-related disorders. By ticking this box https://hermannn780jdu4.blogthisbiz.com/profile